AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $42.2 million versus the consensus estimate of $43.44 million.

Guidance:

Sees FY 2017 revenues up 11-13%

For earnings history and earnings-related data on AtriCure (ATRC) click here.